Found: 103
Select item for more details and to access through your institution.
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.102
- By:
- Publication type:
- Article
624 - Vitiligo biomarker CXCL10 correlates with clinical response in the phase 2 randomized, double-blind, vehicle-controlled TRuE-V mechanism of action study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.008
- By:
- Publication type:
- Article
661 - Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.039
- By:
- Publication type:
- Article
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2077, doi. 10.1007/s13555-024-01210-3
- By:
- Publication type:
- Article
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 856, doi. 10.1001/jamadermatol.2024.2131
- By:
- Publication type:
- Article
Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 4, p. 875, doi. 10.1007/s13555-024-01129-9
- By:
- Publication type:
- Article
Real-world use and effectiveness of upadacitinib in adults and adolescents with atopic dermatitis: preliminary analysis of the real-world multicountry AD-VISE study.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii7, doi. 10.1093/bjd/ljad498.009
- By:
- Publication type:
- Article
Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD).
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii24, doi. 10.1093/bjd/ljad498.028
- By:
- Publication type:
- Article
The Acne Education Project: An educational initiative to improve acne health literacy and promote help‐seeking behavior in young adolescents.
- Published in:
- Pediatric Dermatology, 2024, v. 41, n. 1, p. 51, doi. 10.1111/pde.15472
- By:
- Publication type:
- Article
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 8, p. 1490, doi. 10.1111/jdv.18926
- By:
- Publication type:
- Article
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.013
- By:
- Publication type:
- Article
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 810, doi. 10.1093/bjd/ljad060
- By:
- Publication type:
- Article
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 613, doi. 10.1001/jamadermatol.2023.0846
- By:
- Publication type:
- Article
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 469, doi. 10.1007/s40257-022-00754-4
- By:
- Publication type:
- Article
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
- By:
- Publication type:
- Article
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 3, p. 869, doi. 10.1007/s12325-022-02379-9
- By:
- Publication type:
- Article
Perspectives and knowledge of acne vulgaris among young adolescents.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 2, p. 308, doi. 10.1111/pde.15230
- By:
- Publication type:
- Article
339 Dupilumab 16-week efficacy and safety are robust and consistent in adults over 60 years of age with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii27, doi. 10.1093/bjd/ljac140.033
- By:
- Publication type:
- Article
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 535, doi. 10.1007/s13555-022-00870-3
- By:
- Publication type:
- Article
Measuring h-index and scholarly productivity in academic dermatology in Canada.
- Published in:
- Scientometrics, 2023, v. 128, n. 2, p. 1071, doi. 10.1007/s11192-022-04589-y
- By:
- Publication type:
- Article
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 6, p. 891, doi. 10.1007/s40257-022-00722-y
- By:
- Publication type:
- Article
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 11, p. 2087, doi. 10.1111/jdv.18376
- By:
- Publication type:
- Article
Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15777
- By:
- Publication type:
- Article
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1073, doi. 10.1007/s13555-022-00722-0
- By:
- Publication type:
- Article
Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS).
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 921, doi. 10.1007/s13555-022-00703-3
- By:
- Publication type:
- Article
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 253, doi. 10.1007/s13555-021-00642-5
- By:
- Publication type:
- Article
Treatments for Primary Delusional Infestation: Systematic Review.
- Published in:
- JMIR Dermatology, 2022, v. 5, n. 1, p. 1, doi. 10.2196/34323
- By:
- Publication type:
- Article
Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 1, p. 95, doi. 10.1111/1346-8138.16214
- By:
- Publication type:
- Article
Practical Management of Patients with Atopic Dermatitis on Dupilumab.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1805, doi. 10.1007/s13555-021-00586-w
- By:
- Publication type:
- Article
The COVID-19 pandemic and its skin effects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study.
- Published in:
- American Journal of Clinical Dermatology, 2021, v. 22, n. 4, p. 567, doi. 10.1007/s40257-021-00598-4
- By:
- Publication type:
- Article
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 5, p. 725, doi. 10.1007/s40257-019-00454-6
- By:
- Publication type:
- Article
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Goals and Barriers to Effective Psoriasis Care.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 1, p. 5, doi. 10.1007/s13555-018-0279-5
- By:
- Publication type:
- Article
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 437, doi. 10.1007/s40257-017-0341-6
- By:
- Publication type:
- Article
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 2, p. 275, doi. 10.1007/s40257-018-0352-y
- By:
- Publication type:
- Article
Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2017, v. 13, p. 1, doi. 10.1186/s13223-017-0210-0
- By:
- Publication type:
- Article
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 3, p. 221, doi. 10.1177/1203475415616073
- By:
- Publication type:
- Article
No Evidence for Depression Screening in Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
- Published in:
- 2016
- By:
- Publication type:
- letter
Dr. Roubille, et al reply.
- Published in:
- 2016
- By:
- Publication type:
- letter
Management of acne: Canadian clinical practice guideline.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 1, p. 21, doi. 10.1177/1203475415605498
- By:
- Publication type:
- Article